Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack clinical trials

Explore recruiting prevention of ischemic stroke in patients post acute non cardioembolic ischemic stroke or high risk transient ischemic attack clinical trials.

Also recruiting in Europe

Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

(20604 OCEANIC STROKE) A multicenter, randomized, placebo controlled, double-blind, parallel group and event driven Phase 3 study of the oral FXIa inhibitor asundexian (BAY 2433334) for the prevention of ischemic stroke in male and female participants aged 18 years and older after an acute non-cardioembolic ischemic stroke or high-risk TIA

Slovakia, Latvia, Hungary, Sweden, Netherlands, Austria +14 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A study to learn about the amount of asundexian in the blood when healthy participants take different types of asundexian tablets

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack trials by city

Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack in Toronto Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack in Vancouver Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack in Montreal Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack in Calgary Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack in Edmonton Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack in Ottawa Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack in Winnipeg Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack in Quebec City Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack in Hamilton Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack in Kitchener Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack in London Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack in Halifax Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack in New York Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack in Los Angeles Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack in Chicago Prevention Of Ischemic Stroke In Patients Post Acute Non Cardioembolic Ischemic Stroke Or High Risk Transient Ischemic Attack in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease